Gilead Sciences Inc buy BMO Capital Markets
Start price
17.10.24
/
50%
€80.64
Target price
17.10.25
€86.86
Performance (%)
30.46%
End price
18.10.25
€105.20
Summary
This prediction ended on 18.10.25 with a price of €105.20. The BUY prediction by BMO_Capital_Markets for Gilead Sciences Inc saw massive gains of 30.46%. BMO_Capital_Markets has a follow-up prediction for Gilead Sciences Inc where he still thinks Gilead Sciences Inc is a Buy. Dividends of €3.10 are taken into consideration when calculating the performance. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Gilead Sciences Inc | -1.539% | -1.539% | 15.398% |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% |
Comments by BMO_Capital_Markets for this prediction
In the thread Gilead Sciences Inc diskutieren
Gilead Sciences, Inc. (NASDAQ: GILD) had its price target raised by analysts at BMO Capital Markets from $85.00 to $94.00. They now have an "outperform" rating on the stock.
Ratings data for GILD provided by MarketBeat
In the thread Trading Gilead Sciences Inc
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Gilead Sciences Inc
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€100.00
12.02.25
12.02.25
€110.81
12.02.26
12.02.26
6.58%
22:26
22:26
Stopped prediction by BMO_Capital_Markets for Gilead Sciences Inc
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€105.20
20.10.25
20.10.25
€115.78
20.10.26
20.10.26
-0.94%
22:26
22:26
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€89.58
07.11.24
07.11.24
€94.44
07.11.25
07.11.25
15.85%
08.11.25
08.11.25
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€73.00
16.05.23
16.05.23
€91.88
16.05.24
16.05.24
-14.51%
17.05.24
17.05.24